Related Experiment Video
Updated: May 15, 2026
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Accounting for receptor flexibility and enhanced sampling methods in computer-aided drug design
William Sinko1, Steffen Lindert, J Andrew McCammon
1Biomedical Sciences Program, University of California San Diego, La Jolla, CA 92093-0365, USA.
Chemical Biology & Drug Design
|December 21, 2012
Summary
Protein flexibility is crucial for molecular recognition. Accommodating receptor flexibility in simulations improves ligand-protein binding predictions, aiding drug discovery and personalized medicine.
Area of Science:
- Biochemistry and Molecular Biology
- Computational Chemistry
- Pharmacology
Background:
- Protein flexibility significantly impacts biomolecular recognition and ligand binding.
- Predicting molecular structure changes upon binding is essential for accurate association energy assessments.
- Standard docking algorithms often treat receptors as rigid, limiting accuracy.
Purpose of the Study:
- To review techniques for accommodating receptor flexibility in molecular docking simulations.
- To investigate modifications to rigid receptor docking algorithms.
- To explore enhanced sampling and free energy calculation methods for ligand-protein binding.
Main Methods:
- Review of existing techniques for receptor flexibility in docking.
- Investigation of modified rigid receptor docking algorithms.
- Exploration of enhanced sampling techniques and free energy calculations.
Main Results:
- Accommodating receptor flexibility enhances the accuracy of ligand-protein binding simulations.
- Modified algorithms and enhanced sampling improve predictions of bound structures.
- Accurate binding energy assessments are crucial for drug discovery.
Conclusions:
- Understanding and incorporating protein flexibility improves computational simulations of ligand-protein binding.
- These advancements can enhance the efficiency of drug discovery and development.
- Accurate simulations are vital for the advancement of personalized medicine.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...